DR. Nicholas Mcandrew, M.D. is a hematology and oncology internal medicine in Los Angeles, CA with 12 years of experience. The provider is an internist doctor of osteopathy that specializes in the treatment of the combination of hematology and oncology disorders. A doctor of osteopathy that is board eligible/certified by the American Osteopathic Board of Internal Medicine WAS able to obtain a Certificate of Special Qualifications in the field of Hematology and Oncology. The Certificate is NO longer offered. DR. Nicholas Mcandrew, M.D. NPI is 1093074106. The provider is registered as an individual entity type.
The NPPES NPI record indicates the provider is a male.
Education
Medical School: PERELMAN SCHOOL OF MED AT THE UNIVERSITY OF PENNSYLVANIA
Graduation Year:2012
The provider's business location address is:
200 MED PLAZA
365,420,120
LOS ANGELES, CA
ZIP 90024
Phone: (310) 205-0771
The NPI 1093074106 is registered in the Medicare Provider, Enrollment, Chain and Ownership System (PECOS). The provider is legally eligible to order and refer Part B (Clinical Laboratory and Imaging), Durable Medical Equipment, Part A Home Health Agency (HHA), Power Mobility Devices.
The following top HCPCS codes were publicly reported for this provider under the Medicare program for the year 2016. The reported codes are based on the top codes for each available Medicare specialty, excluding evaluation and management codes.
- Complete blood cell count (red cells, white blood cell, platelets), automated test (HCPCS:85025)
- Infusion into a vein for therapy prevention or diagnosis additional sequential infusion up to 1 hour (HCPCS:96367)
- Insertion of needle into vein for collection of blood sample (HCPCS:36415)
- Infusion of chemotherapy into a vein up to 1 hour (HCPCS:96413)
- Injection beneath the skin or into muscle for therapy, diagnosis, or prevention (HCPCS:96372)
- Infusion into a vein for therapy, prevention, or diagnosis up to 1 hour (HCPCS:96365)
The enumeration date for this NPI number is 5/9/2012 and was last updated on 8/9/2018.